MedTrace Logo

Comparison Between Asynchronous Online Care Model With Usual In Office Care for the Management of Atopic Dermatitis

NCT00985894 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 183

Last updated 2017-05-30

No results posted yet for this study

Summary

The purpose of this study is to determine if an asynchronous online model of teledermatology can achieve similar clinical outcomes as compared to conventional in-office care for the management of atopic dermatitis. The investigators also aim to determine the effects of this online care model on patient quality of life as well as patient and physician satisfaction.

The investigators' hypotheses include the following:

1. Compared to in-person visits, the online care model will result in similar clinical improvement in atopic dermatitis disease severity.
2. Compared to in-person visits, the online care model will result in similar improvements in quality of life.
3. Providers and subjects in the online group will achieve a similar level of overall satisfaction as those in the in-person group.

Conditions

Interventions

OTHER

Online Teledermatology Care

Patients randomized to the intervention group will have their scheduled follow-up visits online via store and forward teledermatology.

OTHER

Conventional in Office Care

Patients randomized to the control group will have their scheduled follow-up visits via conventional in office care.

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • April W Armstrong, MD · UC Davis Department of Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00985894 on ClinicalTrials.gov